INCYTE CORPORATION Increase (Decrease) in Accounts Payable
INCYTE CORPORATION (INCY) reported Increase (Decrease) in Accounts Payable of $23.45 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-04-28
- INCYTE CORPORATION increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $23.45M.
- INCYTE CORPORATION increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $32.98M, a 73.10% increase year-over-year.
- INCYTE CORPORATION increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$44.17M, a 244.64% decline year-over-year.
- INCYTE CORPORATION increase (decrease) in accounts payable for the quarter ending 2025-06-30 was $19.91M.
- INCYTE CORPORATION increase (decrease) in accounts payable for fiscal 2025 was $6.56M, a 92.56% decline from fiscal 2024.
- INCYTE CORPORATION increase (decrease) in accounts payable for fiscal 2024 was $88.16M.
- INCYTE CORPORATION increase (decrease) in accounts payable for fiscal 2023 was -$167.94M, a 259.29% decline from fiscal 2022.
- INCYTE CORPORATION increase (decrease) in accounts payable for fiscal 2022 was $105.44M, a 43.76% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-03-31 | $23.45M 10-Q · filed 2026-04-28 | $56.42M derived: sum of 2 quarters · filed 2026-04-28 | $12.26M derived: sum of 3 quarters · filed 2026-04-28 | $32.17M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-12-31 | $32.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | -$11.19M derived: sum of 2 quarters · filed 2026-02-10 | $8.72M derived: sum of 3 quarters · filed 2026-02-10 | $6.56M 10-K · filed 2026-02-10 |
| 2025-09-30 | -$44.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$24.25M derived: sum of 2 quarters · filed 2025-10-28 | -$26.41M 10-Q · filed 2025-10-28 | -$7.36M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-06-30 | $19.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $17.75M 10-Q · filed 2025-07-29 | $36.80M derived: sum of 3 quarters · filed 2026-04-28 | $67.34M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-03-31 | -$2.16M 10-Q · filed 2026-04-28 | $16.89M derived: sum of 2 quarters · filed 2026-04-28 | $47.43M derived: sum of 3 quarters · filed 2026-04-28 | $31.36M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $19.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $49.59M derived: sum of 2 quarters · filed 2026-02-10 | $33.52M derived: sum of 3 quarters · filed 2026-02-10 | $88.16M 10-K · filed 2026-02-10 |
| 2024-09-30 | $30.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $14.47M derived: sum of 2 quarters · filed 2025-10-28 | $69.11M 10-Q · filed 2025-10-28 | $39.30M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | -$16.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $38.57M 10-Q · filed 2025-07-29 | $8.76M derived: sum of 3 quarters · filed 2026-02-10 | -$7.36M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $54.64M 10-Q · filed 2025-04-29 | $24.83M derived: sum of 2 quarters · filed 2026-02-10 | $8.70M derived: sum of 3 quarters · filed 2026-02-10 | $108.61M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | -$29.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | -$45.94M derived: sum of 2 quarters · filed 2026-02-10 | $53.97M derived: sum of 3 quarters · filed 2026-02-10 | -$167.94M 10-K · filed 2026-02-10 |
| 2023-09-30 | -$16.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $83.78M derived: sum of 2 quarters · filed 2024-10-29 | -$138.13M 10-Q · filed 2024-10-29 | -$23.76M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-06-30 | $99.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | -$122.01M 10-Q · filed 2024-07-30 | -$7.64M derived: sum of 3 quarters · filed 2025-02-10 | -$39.23M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-03-31 | -$221.91M 10-Q · filed 2024-04-30 | -$107.54M derived: sum of 2 quarters · filed 2025-02-10 | -$139.14M derived: sum of 3 quarters · filed 2025-02-10 | -$96.91M derived: sum of 4 quarters · filed 2025-02-10 |
| 2022-12-31 | $114.37M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $82.78M derived: sum of 2 quarters · filed 2025-02-10 | $125.00M derived: sum of 3 quarters · filed 2025-02-10 | $105.44M 10-K · filed 2025-02-10 |
| 2022-09-30 | -$31.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $10.63M derived: sum of 2 quarters · filed 2023-10-31 | -$8.94M 10-Q · filed 2023-10-31 | $48.67M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | $42.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $22.66M 10-Q · filed 2023-08-01 | $80.26M derived: sum of 3 quarters · filed 2024-02-13 | $72.67M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | -$19.56M 10-Q · filed 2023-05-02 | $38.04M derived: sum of 2 quarters · filed 2024-02-13 | $30.45M derived: sum of 3 quarters · filed 2024-02-13 | $67.49M derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | $57.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $50.01M derived: sum of 2 quarters · filed 2024-02-13 | $87.05M derived: sum of 3 quarters · filed 2024-02-13 | $73.34M 10-K · filed 2024-02-13 |
| 2021-09-30 | -$7.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $29.45M derived: sum of 2 quarters · filed 2022-11-01 | $15.74M 10-Q · filed 2022-11-01 | -$8.00M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-06-30 | $37.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $23.33M 10-Q · filed 2022-08-02 | -$412.00K derived: sum of 3 quarters · filed 2023-02-07 | $31.19M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-03-31 | -$13.71M 10-Q · filed 2022-05-03 | -$37.45M derived: sum of 2 quarters · filed 2023-02-07 | -$5.85M derived: sum of 3 quarters · filed 2023-02-07 | $24.12M derived: sum of 4 quarters · filed 2023-02-07 |
| 2020-12-31 | -$23.75M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $7.86M derived: sum of 2 quarters · filed 2023-02-07 | $37.83M derived: sum of 3 quarters · filed 2023-02-07 | $15.12M 10-K · filed 2023-02-07 |
| 2020-09-30 | $31.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $61.58M derived: sum of 2 quarters · filed 2021-11-02 | $38.87M 10-Q · filed 2021-11-02 | $27.14M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-06-30 | $29.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $7.26M 10-Q · filed 2021-08-03 | -$4.47M derived: sum of 3 quarters · filed 2022-02-08 | $19.32M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-03-31 | -$22.71M 10-Q · filed 2021-05-04 | -$34.44M derived: sum of 2 quarters · filed 2022-02-08 | -$10.65M derived: sum of 3 quarters · filed 2022-02-08 | -$9.43M derived: sum of 4 quarters · filed 2022-02-08 |
| 2019-12-31 | -$11.73M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-08 | $12.06M derived: sum of 2 quarters · filed 2022-02-08 | $13.28M derived: sum of 3 quarters · filed 2022-02-08 | -$20.18M 10-K · filed 2022-02-08 |
| 2019-09-30 | $23.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $25.01M derived: sum of 2 quarters · filed 2020-11-05 | -$8.45M 10-Q · filed 2020-11-05 | -$102.00K derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-06-30 | $1.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$32.24M 10-Q · filed 2020-08-04 | -$23.89M derived: sum of 3 quarters · filed 2021-02-09 | -$3.98M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-03-31 | -$33.46M 10-Q · filed 2020-05-05 | -$25.11M derived: sum of 2 quarters · filed 2021-02-09 | -$5.20M derived: sum of 3 quarters · filed 2021-02-09 | -$3.75M derived: sum of 4 quarters · filed 2021-02-09 |
| 2018-12-31 | $8.35M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $28.27M derived: sum of 2 quarters · filed 2021-02-09 | $29.71M derived: sum of 3 quarters · filed 2021-02-09 | $36.16M 10-K · filed 2021-02-09 |
| 2018-09-30 | $19.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | $21.36M derived: sum of 2 quarters · filed 2019-10-29 | $27.81M 10-Q · filed 2019-10-29 | $25.55M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $1.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | $7.89M 10-Q · filed 2019-07-30 | $5.63M derived: sum of 3 quarters · filed 2020-02-13 | $6.47M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | $6.44M 10-Q · filed 2019-04-30 | $4.18M derived: sum of 2 quarters · filed 2020-02-13 | $5.02M derived: sum of 3 quarters · filed 2020-02-13 | -$12.21M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | -$2.26M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | -$1.42M derived: sum of 2 quarters · filed 2020-02-13 | -$18.66M derived: sum of 3 quarters · filed 2020-02-13 | -$7.93M 10-K · filed 2020-02-13 |
| 2017-09-30 | $840.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | -$16.39M derived: sum of 2 quarters · filed 2018-10-30 | -$5.67M 10-Q · filed 2018-10-30 | $12.41M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-06-30 | -$17.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | -$6.51M 10-Q · filed 2018-07-31 | $11.57M derived: sum of 3 quarters · filed 2019-02-14 | $28.37M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-03-31 | $10.73M 10-Q · filed 2018-05-01 | $28.80M derived: sum of 2 quarters · filed 2019-02-14 | $45.60M derived: sum of 3 quarters · filed 2019-02-14 | $52.67M derived: sum of 4 quarters · filed 2019-02-14 |
| 2016-12-31 | $18.07M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $34.88M derived: sum of 2 quarters · filed 2019-02-14 | $41.94M derived: sum of 3 quarters · filed 2019-02-14 | $43.76M 10-K · filed 2019-02-14 |
| 2016-09-30 | $16.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $23.87M derived: sum of 2 quarters · filed 2017-10-31 | $25.68M 10-Q · filed 2017-10-31 | $28.40M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-06-30 | $7.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $8.88M 10-Q · filed 2017-08-01 | $11.60M derived: sum of 3 quarters · filed 2018-02-15 | $9.81M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-03-31 | $1.81M 10-Q · filed 2017-05-04 | $4.53M derived: sum of 2 quarters · filed 2018-02-15 | $2.74M derived: sum of 3 quarters · filed 2018-02-15 | $5.31M derived: sum of 4 quarters · filed 2018-02-15 |
| 2015-12-31 | $2.72M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $923.00K derived: sum of 2 quarters · filed 2018-02-15 | $3.50M derived: sum of 3 quarters · filed 2018-02-15 | $5.62M 10-K · filed 2018-02-15 |
| 2015-09-30 | -$1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $780.00K derived: sum of 2 quarters · filed 2016-11-01 | $2.90M 10-Q · filed 2016-11-01 | $761.00K derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-30 | $2.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $4.70M 10-Q · filed 2016-08-09 | $2.56M derived: sum of 3 quarters · filed 2017-02-14 | $1.91M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-31 | $2.12M 10-Q · filed 2016-05-09 | -$19.00K derived: sum of 2 quarters · filed 2017-02-14 | -$665.00K derived: sum of 3 quarters · filed 2017-02-14 | $8.64M derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-31 | -$2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | -$2.79M derived: sum of 2 quarters · filed 2017-02-14 | $6.51M derived: sum of 3 quarters · filed 2017-02-14 | $5.36M 10-K · filed 2017-02-14 |
| 2014-09-30 | -$646.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | $8.65M derived: sum of 2 quarters · filed 2015-11-03 | $7.50M 10-Q · filed 2015-11-03 | $8.39M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-30 | $9.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $8.15M 10-Q · filed 2015-08-04 | $9.04M derived: sum of 3 quarters · filed 2016-02-12 | $13.78M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-31 | -$1.15M 10-Q · filed 2015-04-30 | -$262.00K derived: sum of 2 quarters · filed 2016-02-12 | $4.48M derived: sum of 3 quarters · filed 2016-02-12 | $2.44M derived: sum of 4 quarters · filed 2016-02-12 |
| 2013-12-31 | $890.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $5.63M derived: sum of 2 quarters · filed 2016-02-12 | $3.59M derived: sum of 3 quarters · filed 2016-02-12 | $5.14M 10-K · filed 2016-02-12 |
| 2013-09-30 | $4.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $2.70M derived: sum of 2 quarters · filed 2014-10-30 | $4.25M 10-Q · filed 2014-10-30 | $5.45M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-30 | -$2.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | -$490.00K 10-Q · filed 2014-07-31 | $707.00K derived: sum of 3 quarters · filed 2015-02-17 | $2.37M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-31 | $1.55M 10-Q · filed 2014-05-01 | $2.75M derived: sum of 2 quarters · filed 2015-02-17 | $4.41M derived: sum of 3 quarters · filed 2015-02-17 | $2.34M derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $2.86M derived: sum of 2 quarters · filed 2015-02-17 | $787.00K derived: sum of 3 quarters · filed 2015-02-17 | -$978.00K 10-K · filed 2015-02-17 |
| 2012-09-30 | $1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | -$410.00K derived: sum of 2 quarters · filed 2013-10-31 | -$2.17M 10-Q · filed 2013-10-31 | $1.73M derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-06-30 | -$2.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | -$3.84M 10-Q · filed 2013-08-01 | $64.00K derived: sum of 3 quarters · filed 2014-02-21 | $2.31M derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-03-31 | -$1.76M 10-Q · filed 2013-05-02 | $2.14M derived: sum of 2 quarters · filed 2014-02-21 | $4.39M derived: sum of 3 quarters · filed 2014-02-21 | $5.38M derived: sum of 4 quarters · filed 2014-02-21 |
| 2011-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $6.15M derived: sum of 2 quarters · filed 2014-02-21 | $7.15M derived: sum of 3 quarters · filed 2014-02-21 | $4.17M 10-K · filed 2014-02-21 |
| 2011-09-30 | $2.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $3.25M derived: sum of 2 quarters · filed 2012-11-01 | $265.00K 10-Q · filed 2012-11-01 | $3.29M derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-06-30 | $997.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | -$1.99M 10-Q · filed 2012-08-03 | $1.04M derived: sum of 3 quarters · filed 2013-02-21 | -$370.00K derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-03-31 | -$2.98M 10-Q · filed 2012-04-26 | $41.00K derived: sum of 2 quarters · filed 2013-02-21 | -$1.37M derived: sum of 3 quarters · filed 2013-02-21 | -$5.51M derived: sum of 4 quarters · filed 2013-02-21 |
| 2010-12-31 | $3.02M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $1.61M derived: sum of 2 quarters · filed 2013-02-21 | -$2.53M derived: sum of 3 quarters · filed 2013-02-21 | -$10.19M 10-K · filed 2013-02-21 |
| 2010-09-30 | -$1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | -$5.55M derived: sum of 2 quarters · filed 2011-10-27 | -$13.21M 10-Q · filed 2011-10-27 | |
| 2010-06-30 | -$4.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | -$11.81M 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | -$7.66M 10-Q · filed 2011-05-03 | |||
| 2009-12-31 | $5.29M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |